Primary Objective:
To determine the bioequivalence of a single dose of the commercial tablet of sotagliflozin
(test) compared to the development tablet of sotagliflozin (reference) under fasting
conditions in healthy male and female subjects.
Secondary Objectives:
- To evaluate the single-dose pharmacokinetics of sotagliflozin and its main metabolite
sotagliflozin 3-O-glucuronide following administration of a single sotagliflozin (test)
tablet or a single sotagliflozin (reference) table in healthy male and female subjects
under fasting conditions.
- To evaluate safety and tolerability of a single dose sotagliflozin (test) tablet
compared to a single sotagliflozin (reference) tablet administered under fasted
conditions in healthy male and female subjects.